Phase II trial of S-1 in combination with gemcitabine for chemo-naïve patients with locally advanced or metastatic pancreatic cancer

被引：0
|
作者：
Gyeong-Won Lee
Hye Jung Kim
Ji-Hyun Ju
Seok-Hyun Kim
Hoon Gu Kim
Tae Hyo Kim
Hyun Jin Kim
Chi-Young Jeong
Jung Hun Kang
机构：
[1] Gyeongsang National University,Division of Hematology
[2] Gyeongsang Institute of Health Science,Oncology, Department of Internal Medicine, College of Medicine
[3] Gyeongnam Regional Cancer Center,Department of Pharmacology, School of Medicine
[4] Gyeongsang National University,Department of Surgery, School of Medicine
[5] Gyeong-Sang National University,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2009年 / 64卷
关键词：
Gemcitabine; S-1; Pancreatic cancer; Combination chemotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Phase II trial of S-1 in combination with gemcitabine for chemo-na⟨ve patients with locally advanced or metastatic pancreatic cancer
    Lee, Gyeong-Won
    Kim, Hye Jung
    Ju, Ji-Hyun
    Kim, Seok-Hyun
    Kim, Hoon Gu
    Kim, Tae Hyo
    Kim, Hyun Jin
    Jeong, Chi-Young
    Kang, Jung Hun
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 64 (04) : 707 - 713
  • [2] Phase II trial of S-1 in combination with gemcitabine in chemo-naive patients with locally advanced or metastatic pancreatic cancer
    Lee, G.
    Kim, H.
    Kang, M.
    Kim, T.
    Kim, H.
    Kang, J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [3] Phase II trial of gemcitabine and S-1 for patients with advanced pancreatic cancer
    Song, Hunho
    Han, Boram
    Park, Choong Kee
    Kim, Jong Hyeok
    Jeon, Jang Yong
    Kim, In-Gyu
    Kim, Hyo Jung
    Jung, Joo Young
    Kim, Jung Han
    Kwon, Jung Hye
    Jang, Geundoo
    Kim, Ho Young
    Kim, Hyeong Su
    Choi, Dae Ro
    Zang, Dae Young
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 72 (04) : 845 - 852
  • [4] Phase II trial of gemcitabine and S-1 for patients with advanced pancreatic cancer
    Hunho Song
    Boram Han
    Choong Kee Park
    Jong Hyeok Kim
    Jang Yong Jeon
    In-Gyu Kim
    Hyo Jung Kim
    Joo Young Jung
    Jung Han Kim
    Jung Hye Kwon
    Geundoo Jang
    Ho Young Kim
    Hyeong Su Kim
    Dae Ro Choi
    Dae Young Zang
    [J]. Cancer Chemotherapy and Pharmacology, 2013, 72 : 845 - 852
  • [5] A phase II trial of gemcitabine, S-1 and LV combination therapy in patients with advanced pancreatic cancer
    Saito, K. O.
    Nakai, Y.
    Isayama, H.
    Ishigaki, K.
    Saito, T.
    Takahara, N.
    Mizuno, S.
    Kogure, H.
    Koike, K.
    [J]. ANNALS OF ONCOLOGY, 2018, 29
  • [6] Combination Chemoherapy with S-1 and Gemcitabine for Locally Advanced and/or Metastatic Unresectable Pancreatic Cancer
    Takayama, Yukiko
    Shimizu, Kyoko
    Tahara, Junko
    Oyama, Hiroyasu
    Hayashi, Kazuhiko
    Shiratori, Keiko
    [J]. GASTROENTEROLOGY, 2009, 136 (05) : A314 - A314
  • [7] A phase II trial of gemcitabine, S-1 and LV combination (GSL) therapy in patients with advanced pancreatic cancer
    Saito, Kei
    Isayama, Hiroyuki
    Nakai, Yousuke
    Takahara, Naminatsu
    Ishigaki, Kazunaga
    Takeda, Tsuyoshi
    Hakuta, Ryunosuke
    Saito, Tomotaka
    Uchino, Rie
    Kishikawa, Takahiro
    Hamada, Tsuyoshi
    Mizuno, Suguru
    Sasaki, Takashi
    Kogure, Hirofumi
    Matsubara, Saburo
    Yamamoto, Natsuyo
    Ijichi, Hideaki
    Tateishi, Keisuke
    Tada, Minoru
    Koike, Kazuhiko
    [J]. INVESTIGATIONAL NEW DRUGS, 2019, 37 (02) : 338 - 344
  • [8] A phase II trial of gemcitabine, S-1 and LV combination (GSL) therapy in patients with advanced pancreatic cancer
    Kei Saito
    Hiroyuki Isayama
    Yousuke Nakai
    Naminatsu Takahara
    Kazunaga Ishigaki
    Tsuyoshi Takeda
    Ryunosuke Hakuta
    Tomotaka Saito
    Rie Uchino
    Takahiro Kishikawa
    Tsuyoshi Hamada
    Suguru Mizuno
    Takashi Sasaki
    Hirofumi Kogure
    Saburo Matsubara
    Natsuyo Yamamoto
    Hideaki Ijichi
    Keisuke Tateishi
    Minoru Tada
    Kazuhiko Koike
    [J]. Investigational New Drugs, 2019, 37 : 338 - 344
  • [9] A phase II trial of gemcitabine, S-1 and LV combination (GSL) neoadjuvant chemotherapy for patients with borderline resectable and locally advanced pancreatic cancer
    Kei Saito
    Hiroyuki Isayama
    Yoshihiro Sakamoto
    Yousuke Nakai
    Kazunaga Ishigaki
    Mariko Tanaka
    Takeyuki Watadani
    Junichi Arita
    Naminatsu Takahara
    Suguru Mizuno
    Hirofumi Kogure
    Hideaki Ijichi
    Keisuke Tateishi
    Minoru Tada
    Kiyoshi Hasegawa
    Masashi Fukayama
    Norihiro Kokudo
    Kazuhiko Koike
    [J]. Medical Oncology, 2018, 35
  • [10] A phase II trial of gemcitabine, S-1 and LV combination (GSL) neoadjuvant chemotherapy for patients with borderline resectable and locally advanced pancreatic cancer
    Saito, Kei
    Isayama, Hiroyuki
    Sakamoto, Yoshihiro
    Nakai, Yousuke
    Ishigaki, Kazunaga
    Tanaka, Mariko
    Watadani, Takeyuki
    Arita, Junichi
    Takahara, Naminatsu
    Mizuno, Suguru
    Kogure, Hirofumi
    Ijichi, Hideaki
    Tateishi, Keisuke
    Tada, Minoru
    Hasegawa, Kiyoshi
    Fukayama, Masashi
    Kokudo, Norihiro
    Koike, Kazuhiko
    [J]. MEDICAL ONCOLOGY, 2018, 35 (07)
12345